Electromed Stock Price, News & Analysis

Electromed, Inc. (AMEX: ELMD) announced its financial results for the fiscal 2022 third quarter, ending March 31, 2022, will be released on May 10, 2022, after market close. A conference call to discuss these results will follow at 5:00 p.m. Eastern Time on the same day. Participants can join by dialing specific numbers provided in the release. For those unable to attend, a replay will be available via phone and online.

Electromed, Inc. has appointed Christopher Holland as Chief Commercial Officer to spearhead its strategic growth initiatives. With 30 years of experience in the Medical Technology sector, Holland previously held significant roles at Prosomnus Sleep Technologies and Nonin Medical, where he drove substantial revenue growth. CEO Kathleen Skarvan expressed confidence in Holland's ability to enhance marketing and sales strategies that align with the company’s revenue goals and shareholder value. This leadership shift aims to position Electromed prominently within the airway clearance market.

Electromed, Inc. (NYSE American: ELMD) reported record quarterly net revenues of $10.2 million for the fiscal second quarter ended December 31, 2021, up from $9.5 million year-over-year. Home care revenues drove this growth, totaling $9.4 million, despite a decline in gross profit margin to 76.9% due to rising raw material and shipping costs. Operating income decreased to $1.1 million, with net income at $0.8 million or $0.10 per diluted share. The company plans to continue strategic growth initiatives, including a focus on expanding its sales force and developing new product offerings.

Electromed, Inc. (AMEX: ELMD) announced that it will release its financial results for the fiscal 2022 second quarter, ending December 31, 2021, on February 8, 2022, after the market closes. A conference call to discuss these results will be held at 5:00 p.m. ET on the same day, accessible via phone for domestic and international callers. The event can also be streamed live on the Investor Relations section of their website.

Electromed, a leader in airway clearance technologies, announced its participation in the Sidoti December Virtual Micro Cap Investor Conference on December 8-9, 2021. Key executives, including President Kathleen Skarvan and CFO Mike MacCourt, will present on December 8 at 2:30 p.m. Eastern Time and will be available for one-on-one meetings. Electromed is known for its SmartVest® Airway Clearance System, aimed at patients with compromised pulmonary function. The Company is based in New Prague, Minnesota, and has been operational since 1992.

Electromed, Inc. (NYSE American: ELMD) reported a record quarterly revenue of $10.0 million for Q1 FY 2022, reflecting a 25.0% increase year-over-year. Growth was driven by a 24.4% rise in home care revenue to $9.3 million and a 61.5% increase in institutional revenue. Gross profit margin improved to 77.0% despite rising costs. However, net income declined to $439,000 or $0.05 per diluted share. SG&A expenses rose to $6.8 million due to strategic investments. The company maintains $11.0 million in cash and continues to focus on product development and digital marketing strategies.

Electromed, Inc. (AMEX: ELMD) will release its fiscal 2022 Q1 financial results on November 9, 2021, after market close. A conference call will follow at 5:00 p.m. Eastern Time to discuss these results. Interested parties can join via phone or through a live webcast available on the company’s website. Electromed is known for its innovative airway clearance technologies, particularly the SmartVest Airway Clearance System, catering to patients with compromised pulmonary function.

Electromed, Inc. (NYSE: ELMD) has announced a cooperation agreement with Summers Value Partners, which holds 5.9% of its stock, leading to the nomination of two new independent directors, Kathy Tune and Joe Galatowitsch, for the upcoming Fiscal 2022 Annual Meeting. A new Finance and Strategy Committee will be formed to enhance value creation. Retiring board members Steve Craney and George Winn will leave their positions. The company highlighted its commitment to growth, showcasing a strategy that aims for double-digit revenue growth and profitability.

Electromed, Inc. (AMEX: ELMD) has announced that its President and CEO, Kathleen Skarvan, along with CFO Mike MacCourt, will participate in the 2021 Colliers Institutional Investor Conference on September 9, 2021. The conference will be held virtually, highlighting the company’s commitment to engaging with investors and stakeholders. Electromed specializes in airway clearance technologies, notably the SmartVest® Airway Clearance System, to assist patients with compromised pulmonary function. The company is based in New Prague, Minnesota, and has been operational since 1992.